To date, the role of ERVK env in disease remains highly debated, and it has been proposed that proteins other than canonical full-length Env should be considered when examining the role of ERVK in ALS disease [11]. This evidence concerns the gene ERVW-1 and amyotrophic lateral sclerosis.